Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzedrex
2. Propylhexadrine
3. Propylhexedrine Hydrochloride
4. Propylhexedrine Hydrochloride, (s)-isomer
1. Benzedrex
2. Hydromethamphetamine
3. Propylhexedrin
4. Dristan
5. Obesin
6. Hexahydrodesoxyephedrine
7. Dristan Inhaler
8. Chp-depot
9. 1-cyclohexyl-n-methylpropan-2-amine
10. 101-40-6
11. Propylhexadrine
12. Propylhexedrinum
13. Dl-propylhexedrine
14. Methyl-(1-methyl-2-cyclohexylethyl)amine
15. 1-cyclohexyl-2-(methylamino)propane
16. 1-cyclohexyl-n-methyl-2-propanamine
17. (+/-) Propylhexedrine
18. N,alpha-dimethylcyclohexaneethylamine
19. Nsc 32410
20. 1-cyclohexyl-2-methylaminopropan
21. Cyclohexaneethanamine, N,.alpha.-dimethyl-
22. Nsc-32410
23. Lqu92iu8ll
24. Ncgc00182042-01
25. Cyclohexaneethylamine, N-.alpha.-dimethyl-
26. Propilhexedrina
27. Propilesedrina
28. Propilesedrina [dcit]
29. Einecs 202-939-3
30. Unii-lqu92iu8ll
31. Brn 3194303
32. Propylhexedrinum [inn-latin]
33. 1-cyclohexyl-2-methylaminopropan [german]
34. Propilhexedrina [inn-spanish]
35. (+-)-n,alpha-dimethylcyclohexaneethylamine
36. (cyclohexaneethyl)amine, N-alpha-dimethyl-
37. Beta-cyclohexyl-isopropylmethylamin [german]
38. Propylhexedrine [usp:inn:ban]
39. Beta-cyclohexyl-isopropylmethylamin
40. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)
41. Einecs 222-741-0
42. Dristan Inhaler (tn)
43. Propylhexedrine Dl-form
44. Dsstox_cid_3526
45. Cyclohexaneethylamine, Alpha,n-dimethyl-
46. Propylhexedrine (usp/inn)
47. Dsstox_rid_77064
48. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)-
49. Dsstox_gsid_23526
50. Schembl28537
51. Propylhexedrine [inn]
52. 3-12-00-00108 (beilstein Handbook Reference)
53. Propylhexedrine [vandf]
54. Propylhexedrine [mart.]
55. Chembl2105275
56. Dtxsid1023526
57. Propylhexedrine [who-dd]
58. Schembl20780004
59. Wln: L6tj A1y1&m1
60. Chebi:134783
61. N-methyl-1-cyclohexylisopropylamine
62. Nsc32410
63. Tox21_113077
64. Propylhexedrine Dl-form [mi]
65. Stk664138
66. Akos005172629
67. .alpha.,n-dimethylcyclohexaneethylamine
68. Cyclohexaneethanamine,.alpha.-dimethyl-
69. Db06714
70. N,.alpha.-dimethylcyclohexaneethylamine
71. Propylhexedrine [usp Monograph]
72. (1-cyclohexylpropan-2-yl)(methyl)amine
73. Ncgc00182042-03
74. Ncgc00182042-04
75. 3595-11-7
76. Cas-101-40-6
77. N-.alpha.-(dimethylcyclohexane)ethylamine
78. Cyclohexaneethylamine, .alpha.,n-dimethyl-
79. Ft-0674106
80. (cyclohexaneethyl)amine, N-.alpha.-dimethyl-
81. N-(2-cyclohexyl-1-methylethyl)-n-methylamine
82. D05637
83. Ab01331925-02
84. (.+/-.)-n,.alpha.-dimethylcyclohexaneethylamine
85. Q408704
86. (+/-)-n,.alpha.-dimethylcyclohexaneethanamine
87. Cyclohexaneethanamine, N,.alpha.-dimethyl-, (.+/-.)
Molecular Weight | 155.28 g/mol |
---|---|
Molecular Formula | C10H21N |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Exact Mass | 155.167399674 g/mol |
Monoisotopic Mass | 155.167399674 g/mol |
Topological Polar Surface Area | 12 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 95 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
It is used to provide temporary symptomatic relief of nasal congestion due to colds, allergies and allergic rhinitis.
Like other monoamine releasing stimulants propylhexedrine is active as a norepinephrine and dopamine releaser in the central nervous system. The acute effects of the drug closely resemble the physiological and psychological effects of an epinephrine-provoked fight-or-flight response, including increased heart rate and blood pressure, vasoconstriction (constriction of the arterial walls), bronchodilation, and hyperglycemia (increased blood sugar).
Propylhexidrine causes the norepinephrine, dopamine, and serotonin (5HT) transporters to reverse their direction of flow. This inversion leads to a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse. It also antagonizes the action of VMAT2, causing the release of more neurotransmitters.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?